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Purpose: The Rotarex® catheter system is an effective tool for endovascular therapy of acute 
occluded arteries of the lower extremities, especially for the femoral artery. The authors report 
the use of the Rotarex catheter system for retrograde percutaneous thrombectomy of an occluded 
subclavian artery.
Case presentation: A 79-year-old male patient was referred because of acute pain and pale-
ness of his left arm. Ultrasound examination and computed tomography angiography proved an 
occlusion of the left subclavian artery from the origin of the vessel. A retrograde recanalization 
was attempted using the 6F Rotarex catheter and combined with initiation of a local low-dose 
lytic therapy. A normal blood flow to the left arm was restored. Follow-up examination 3 months 
later showed a normal perfusion situation of the left upper extremity.
Conclusion: The Rotarex catheter system is an effective tool for endovascular therapy of acute 
occluded arteries and efficacy is not restricted to the lower extremities.
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Introduction
Subclavian artery thrombosis is a condition in which the blood flow through the vessel 
is obstructed. Typical symptoms occur secondary to lack of blood flow to the affected 
extremity. In situations in which the occlusion is secondary to atherosclerosis, acute 
and subacute thrombosis of the artery is generally minimally symptomatic.1 On the 
other hand, symptoms of acute embolic occlusion of the subclavian artery are com-
monly associated with claudication or rest pain on the affected side. Therapeutic 
intervention is indicated in any symptomatic patient. Surgical treatment (Fogarty 
balloon thrombectomy, subclavian bypass operation) and local lysis infiltration have 
been the treatments of choice over recent decades.
Nowadays, modern endovascular thrombectomy devices that use different meth-
ods of thrombus fragmentation and transportation are commercially available. Some 
of these devices use the vortex principle to fragment the thrombus (eg, the Amplatz 
and the AngioJet® thrombectomy catheters) or the Venturi effect (eg, the Hydrolyser® 
thrombectomy catheter). One of the most promising devices, which combines clot 
fragmentation and removal of the fragmented material using Archimedes’ principle, is 
the Rotarex® catheter (Straub Medical AG, Wangs, Switzerland). It prevents peripheral 
embolization of the fragmented thrombus by negative pressure. Today the effect of the 
Rotarex device in lower extremity arteries for recanalization of acute occluded arter-
ies is accepted, but different case reports describe interventional settings in which the 
system has also been used in other vascular regions.2–4 The authors report the   retrograde 
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use of this device via the brachial artery in a patient with acute 
thrombotic occlusion of the left subclavian artery, which was 
occluded from the origin of the vessel.
Case presentation
A 79-year-old male patient with history of a stroke was 
referred to the authors’ cardiovascular clinic because of an 
acute left arm ischemia. The pain in his left arm occurred 
1 day before admission. The pain was not present during 
rest but it occurred with slight movement of the extremity. 
No cardiac history was reported previously. On physical 
examination the left fingers were pale and no pulse was pal-
pable beyond the left axilla. Systolic blood pressure of the 
left arm was 40 mmHg; on the right side it was 125 mmHg. 
Doppler examination of the left arm showed a typical post-
stenotic flow of the brachial artery and minimal flow of the 
radial and ulnar arteries. Duplex ultrasound demonstrated 
a thrombotic occlusion of the visible left subclavian artery 
and part of the axillary artery. The brachial artery was free 
of thrombus formation.
A computed tomography (CT) angiogram was performed 
that proved the thrombotic occlusion of the left subclavian 
artery beginning at the origin of the vessel (Figure 1A); the 
CT scan also proved the thrombotic occlusion of the proximal 
part of the axillary artery. The vertebral artery was involved 
in the thrombotic process, showing only a low retrograde 
Doppler signal in ultrasound examination. In the authors’ 
view, the reason for this thrombotic occlusion seemed to be a 
thrombotic formation based on a stenosis of the proximal part 
of the subclavian artery. Transthoracic and transesophageal 
echocardiography could not identify a cardiac source of the 
embolic event. The electrocardiogram was monitored over 
a 24-hour period without documented arrhythmias.
Because of the involved origin of the left subclavian artery, 
it was decided that a retrograde attempt to reopen the thrombotic 
occlusion would be performed. The puncture of the not-palpable 
brachial artery was easily achieved by using ultraound guidance. 
Five thousand units of heparin were administered after insertion 
of a 6F Terumo sheath (Terumo Europe NV , Leuven, Belgium). 
Contrast dye was then injected retrograde through the introducer 
sheath and the end of the thrombotic occlusion was docu-
mented (Figure 1B). For the next step, a 0.018-inch guide wire 
(Cruiser-18; Biotronik, Buelach, Switzerland) was advanced 
retrograde through the occluded subclavian artery; it found 
the way easily into the descending aorta. Using a 5F pigtail 
catheter (Medtronic GmbH, Meerbusch, Germany), which was 
advanced proximally of the occlusion, the anatomic situation 
was documented and overlay images were prepared for a   
rotational thrombectomy. A 6F Rotarex device was then passed 
over the 0.018-inch guide wire and through the occlusion 
four times (Figures 2A and B). After this procedure most of 
the thrombotic material was removed, but still some thrombotic 
formations were documented in the subclavian and axillary 
arteries. By this time a 70% stenosis of the proximal subclavian 
artery was visible as the probable underlying reason for the 
thrombotic occlusion.
A self-expandable nitinol stent (LifeStent® 6 × 30 mm; 
C.R. Bard GmbH, Karlsruhe, Germany) was then implanted in 
the stenosis without any problems and it showed a good result 
after the implantation and post dilatation. After removing 
most of the thrombotic material, a systolic blood pressure of 
90 mmHg at the tip of the introducer sheath was documented. 
Figure 1 (A) Computed tomography angiogram of the left subclavian artery with 
thrombotic occlusion from the origin of the artery and (B) retrograde contrast injection 
through the introducer sheath demonstrates the end of the thrombotic occlusion.
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Because of the remaining thrombotic material that was also 
present near the origin of the subclavian artery, a decision was 
made in this situation to perform an additional local low-dose 
lytic therapy. A lysis catheter (C.R. Bard GmbH, Karlsruhe, 
Germany) was advanced into the subclavian artery and 5 mg 
bolus of recombinant tissue plasminogen activator (r-tPA) 
(Actilyse®; Boehringer Ingelheim GmbH, Ingelheim am 
Rhein, Germany) was locally injected, followed by continuous 
administration of 2 mg/hr of r-tPA for 20 hours.
The following day, an angiogram performed through 
the femoral artery documented completely recanalized 
subclavian and axillary arteries without any remaining 
thrombus and the patent nitinol stent at the origin of the 
subclavian artery (Figures 3A and B). The patient was 
discharged from the intensive care unit. Doppler pressure 
measurement showed only a slight difference of 15 mmHg 
in brachial, radial, and ulnar pressures. The reason for the 
slight difference in blood pressure between the right and 
left brachial artery remained unclear. No further invasive 
diagnostic procedures such as intravascular ultrasound were 
performed because there was no expected benefit for the 
clinical result of the patient, who remained asymptomatic 
after the recanalization procedure. The patient was started on 
Figure 2 (A) and (B) 6F Rotarex® catheter in position.
Figure 3 (A) Left subclavian artery 1 day after recanalization and stent implantation 
and (B) left axillary and brachial arteries after low-dose local lysis demonstrate a 
completely recanalized vessel without thrombotic material.
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dual antiplatelet therapy immediately after the   intervention. 
Follow-up examinations after 3 months documented a per-
sistence of the Doppler pressures.
Discussion
Acute and subacute ischemia of the extremities is still one of 
the most frequent reasons for amputation. There are different 
endovascular options for reperfusion therapy including bal-
loon thrombectomy, local lysis, and rotational thrombectomy. 
Balloon thrombectomy, the standard surgical treatment, has 
proven an effective tool for the treatment of acute vascular 
obstructions. Nevertheless, technical problems and compli-
cations can occur. Localized lysis, on the other hand, can 
be time-consuming and expensive, requiring intensive care 
monitoring and angiograms after lytic therapy. Over recent 
years, considerable advances have been made in endovascular 
interventions for the treatment of acute and subacute isch-
emia. The authors used the Rotarex rotational thrombectomy 
device for reopening the subclavian artery in combination 
with local low-dose lytic therapy. The combination of rota-
tional thrombectomy and localized lysis in this case restored 
complete perfusion in the left arm.
The Rotarex catheter (Figure 4) consists of three mod-
ules. A control console is connected to the electric motor that 
rotates the thrombectomy catheter via an electromagnetic 
clutch. Within the catheter, a coated steel spiral rotates at 
40.000 rpm, which produces a vacuum. This vacuum draws 
the thrombotic material into two lateral openings of the cath-
eter and fragments it. The fragmented thrombotic material 
is then transported, via the rotating spiral, into an external 
collection bag. The Rotarex catheter should be slowly 
advanced into the occlusion with some short retractions. 
Some contraindications must be ruled out before the use 
of the Rotarex catheter. A subintimal position of the guide 
wire could lead to a   perforation of the vessel when using the 
device in this   situation. A vessel diameter below 4 mm is a 
contraindication for use of the device because of possible 
vessel damage. Also, the Rotarex catheter should never be 
used without guide wire. The challenge in this particular 
case was the total occlusion of the subclavian artery from 
the origin. After advancing the guide wire retrograde through 
the occlusion into the aorta, the Rotarex catheter was pushed 
near the origin and a pullback maneuver was performed. 
After 5 minutes and four passages there was an acceptable 
antegrade flow with a blood pressure of 90 - 100 mmHg at 
the tip of the 6F introducer sheath. Because of the remain-
ing thrombus near the origin of the vessel, it was decided 
that a lysis catheter would be placed to install a low-dose 
lysis. The advantage of the combination therapy of rotational 
thrombectomy and local low-dose lysis in this setting is the 
minimization of bleeding complications. The patient was 
started on dual antiplatelet therapy for 4 weeks following 
the stent implantation.
Explanations for the thromboembolic complication 
other than the stenosis of the subclavian artery were not 
found. As in this case, the most probable cause of acute 
occlusion of the subclavian artery is the underlying ath-
erosclerotic plaque, with rupture of the plaque and local 
thrombus formation. Most of the other common reasons 
could be ruled out, such as thoracic outlet syndrome 
induced by chronic extra-arterial compression from cos-
toclavicular syndrome or cervical rib syndrome.5–7 There 
were no signs of rheumatic disorders, including arteritis 
such as Takayasu disease, giant cell arteritis, and polymy-
algia rheumatica, which could also lead to an occlusion 
of the subclavian vessel.8 No aneurysm of the subclavian 
artery was documented as an underlying reason for the 
thrombotic occlusion.9 Follow-up examination 3 months 
later demonstrated an open subclavian artery with just a 
slight difference of 10 mmHg between both arms in Dop-
pler pressure examination.
Conclusion
In summary, compared with the established therapies, the 
rotational thrombectomy principle of using the Rotarex 
catheter system together with optional local low-dose lysis 
in an acute occluded subclavian artery is a promising thera-
peutic option.
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